GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Professional Medical Expertise Company SJSC 9574.SR · SAR

Health Care · Tadawul · 🇸🇦 Saudi Arabia

Compare

79.90

—

Close of 9 Nov 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SAR, from our data supplier.

FY2025

Revenue

SAR 418.8m

FY2020FY2025

Net income

SAR 41.7m

FY2020FY2025

Free cash flow

−SAR 34.4m

FY2020FY2025

Shareholders' equity

SAR 150.2m

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
RevenueSAR 418.8mSAR 313.2mSAR 250.1mSAR 176.1mSAR 131.3mSAR 74.4m
Gross profitSAR 176.4mSAR 133.9mSAR 112.0mSAR 80.6mSAR 64.5mSAR 37.9m
Operating incomeSAR 59.6mSAR 39.7mSAR 33.3mSAR 26.0mSAR 24.5mSAR 11.6m
Net incomeSAR 41.7mSAR 27.7mSAR 24.8mSAR 19.0mSAR 20.6mSAR 9.3m
Diluted earnings per share11.927.907.105.435.892.66

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assetsSAR 422.6mSAR 321.1mSAR 279.3mSAR 199.2mSAR 165.1mSAR 115.0m
Cash and short-term investmentsSAR 3.8mSAR 4.9mSAR 951,865SAR 5.3mSAR 17.8mSAR 5.4m
Total liabilitiesSAR 272.4mSAR 207.9mSAR 182.1mSAR 126.0mSAR 125.3mSAR 91.1m
DebtSAR 125.7mSAR 95.5mSAR 64.4mSAR 58.5mSAR 37.9mSAR 36.8m
Shareholders' equitySAR 150.2mSAR 113.2mSAR 97.2mSAR 73.2mSAR 39.8mSAR 23.9m
Shares outstanding4m4m4m4m4m4m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−SAR 10.2m−SAR 1.9mSAR 5.9m−SAR 8.3mSAR 18.5mSAR 10.7m
Capital spending−SAR 24.2m−SAR 6.6m−SAR 9.0m−SAR 6.5m−SAR 3.3m−SAR 2.1m
Free cash flow−SAR 34.4m−SAR 8.5m−SAR 3.1m−SAR 14.8mSAR 15.2mSAR 8.7m
Dividends paid−SAR 3.5m−SAR 10.0m—−SAR 16.0m−SAR 2.9m−SAR 17.1m

Latest quarters

By quarter end

Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023
RevenueSAR 95.0mSAR 95.0mSAR 81.9mSAR 81.9mSAR 74.7mSAR 74.7mSAR 65.7mSAR 65.7m
Gross profitSAR 42.5mSAR 42.5mSAR 37.2mSAR 37.2mSAR 32.2mSAR 32.2mSAR 29.5mSAR 29.5m
Operating incomeSAR 13.6mSAR 13.6mSAR 11.1mSAR 11.1mSAR 9.5mSAR 9.5mSAR 9.6mSAR 9.6m
Net incomeSAR 11.1mSAR 11.1mSAR 7.8mSAR 7.8mSAR 6.1mSAR 6.1mSAR 7.8mSAR 7.8m
Diluted earnings per share3.163.162.222.221.731.732.242.24
Cash from operationsSAR 1.0mSAR 1.0mSAR 5.0mSAR 5.0m−SAR 6.0m−SAR 6.0mSAR 8.0mSAR 8.0m
Capital spending−SAR 6.0m−SAR 6.0m−SAR 1.0m−SAR 1.0m−SAR 2.0m−SAR 2.0m−SAR 2.0m−SAR 2.0m
Free cash flow−SAR 5.0m−SAR 5.0mSAR 4.0mSAR 4.0m−SAR 8.0m−SAR 8.0mSAR 6.0mSAR 6.0m
Total assetsSAR 384.1mSAR 384.1mSAR 321.1mSAR 321.1mSAR 307.1mSAR 307.1mSAR 279.3mSAR 279.3m
Cash and short-term investmentsSAR 7.2mSAR 7.2mSAR 4.9mSAR 4.9mSAR 7.4mSAR 7.4mSAR 951,865SAR 951,865
DebtSAR 108.7mSAR 108.7mSAR 92.4mSAR 92.4mSAR 99.1mSAR 99.1mSAR 61.8mSAR 61.8m
Shareholders' equitySAR 131.8mSAR 131.8mSAR 113.2mSAR 113.2mSAR 99.3mSAR 99.3mSAR 97.2mSAR 97.2m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue33.5%41.3%—
Operating income31.8%38.6%—
Net income29.9%35.0%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin42.4%43.4%44.4%—
Operating margin13.6%13.7%14.3%—
Net margin9.5%9.8%10.5%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023
Price to earnings8.111.410.1
Price to sales0.81.01.0

Dividends and splits

Per share, in the currency the company pays

Paid for 3 years. Last went ex-dividend on 25 Jun 2025.

FY2025FY2023
Paid in the year1.005.70

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.